US20210332022A1 - Dihydrofuran chalcone compound and preparation method thereof - Google Patents

Dihydrofuran chalcone compound and preparation method thereof Download PDF

Info

Publication number
US20210332022A1
US20210332022A1 US16/626,943 US201816626943A US2021332022A1 US 20210332022 A1 US20210332022 A1 US 20210332022A1 US 201816626943 A US201816626943 A US 201816626943A US 2021332022 A1 US2021332022 A1 US 2021332022A1
Authority
US
United States
Prior art keywords
extract
methanol
morus alba
extraction
dihydrofuran
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US16/626,943
Other versions
US11161829B1 (en
Inventor
Bao Yang
Yueming Jiang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
South China Botanical Garden of CAS
Original Assignee
South China Botanical Garden of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by South China Botanical Garden of CAS filed Critical South China Botanical Garden of CAS
Assigned to SOUTH CHINA BOTANICAL GARDEN, CHINESE ACADEMY OF SCIENCES reassignment SOUTH CHINA BOTANICAL GARDEN, CHINESE ACADEMY OF SCIENCES ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: JIANG, YUEMING, YANG, Bao
Publication of US20210332022A1 publication Critical patent/US20210332022A1/en
Application granted granted Critical
Publication of US11161829B1 publication Critical patent/US11161829B1/en
Active legal-status Critical Current
Adjusted expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80Radicals substituted by oxygen atoms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Definitions

  • the present invention relates to the field of natural product chemistry, particularly relates to a dihydrofuran chalcone compound and a preparation method thereof.
  • Morus alba is an evergreen macrophanerophyte in the family Moraceae, widely planted in tropical and subtropical regions. Morus alba fruits are sweet and delicious, with high nutritional value and health-care functions, have the effects of treating canities and anti-inflammatory, and thus are well received by consumers. Morus alba leaves, identified as a new vegetable food material, have a fresh taste and have gradually been accepted by consumers. Studies have found that Morus alba leaves are rich in flavonoids and have biological activities such as anti-oxidation, anti-cancer and immunoregulation. However, there are few studies on the active ingredients of Morus alba leaves, and the composition of related active substances remains to be studied.
  • One object of the present invention is to provide a dihydrofuran chalcone and a preparation method thereof.
  • the dihydrofuran chalcone of the present invention is isolated from a Morus alba leaf, and has a structure according to formula (I):
  • a preparation method of the dihydrofuran chalcone comprises the following steps:
  • Morus alba leaf is provided as Morus alba leaf powders, which are obtained by drying a fresh Morus alba leaf and pulverizing into powders.
  • the aqueous solution of methanol or ethanol is used according to a proportion of 5 to 20 mL/g Morus alba leaf (i.e., 5 to 20 mL of the aqueous solution of methanol or ethanol is used for one gram of the Morus alba leaf), an extraction temperature is 25° C. to 70° C., and an extraction time is 1 to 72 hours.
  • the extract is concentrated at 40° C. to 80° C. to remove methanol or ethanol, and dissolved by adding water wherein a volume of the water is 1 to 5 times that of the concentrated extract.
  • the step of subjecting to extraction with petroleum ether and ethyl acetate successively comprises first extracting with petroleum ether for 3 to 12 times and then extracting with ethyl acetate for 3 to 12 times.
  • the present invention also provides an antioxidant skin care product, medicine or health product, which comprises the dihydrofuran chalcone as an active ingredient.
  • the dihydrofuran chalcone has a high free radical scavenging capacity.
  • An IC 50 value of the compound against DPPH radicals is 32.7 ⁇ M, which is significantly lower than the IC 50 value of positive control vitamin C (Vc) which is 100 ⁇ M, indicating that the dihydrofuran chalcone of the present invention has an excellent antioxidant activity, and thus can be used to prepare antioxidant skin care products, medicines or health products.
  • the present invention has the following advantages:
  • the present invention realizes the preparation of dihydrofuran chalcone by isolating the compound from Morus alba leaves, with a yield of 23 to 157 mg/kg (and a purity of 85% to 95%).
  • the present invention is of great significance for promoting the deep processing and utilization of Morus alba leaves, enhancing the added value of Morus alba leaves products, and promoting the sustainable development of the industry.
  • the invention also provides a novel method for preparing dihydrofuran chalcone.
  • the paste obtained by concentrating the ethyl acetate extracts, was chromatographed over a silica gel column (100-200 mesh) by gradient elution using chloroform-methanol with a volume ratio of 100/0 to 60/40, and an eluate was collected where the volume ratio of chloroform-methanol was 95/5.
  • the eluate was then chromatographed over a C18 reversed-phase column by gradient elution using acetonitrile-water with a volume ratio of 5/95 to 100/0, and an eluate was collected where the volume ratio of acetonitrile-water was 30/70.
  • the eluate was then dried by evaporation concentration at 60° C. to give a compound 1, dihydrofuran chalcone.
  • a yield of the dihydrofuran chalcone was 23 to 49 mg/kg, with a purity of 85% to 95%.
  • the compound 1 was identified to have a structure according to formula (I) and named as dihydrofuran chalcone, easily soluble in methanol.
  • the purification step was identical to that in the embodiment 1 to give the compound 1 which was identified to be dihydrofuran chalcone.
  • a yield of the dihydrofuran chalcone was 115 to 157 mg/kg, with a purity of 85% to 95%.
  • the purification step was identical to that in the embodiment 1 to give the compound 1 which was identified to be dihydrofuran chalcone.
  • a yield of the dihydrofuran chalcone was 55 to 104 mg/kg, with a purity of 85% to 95%.
  • the purification step was identical to that in the embodiment 1 to give the compound 1 which was identified to be dihydrofuran chalcone.
  • a yield of the dihydrofuran chalcone was 48 to 96 mg/kg, with a purity of 85% to 95%.
  • DPPH is a stable free radical.
  • a free radical scavenger When a free radical scavenger is present, light absorption of DPPH will be reduced when the single electron is scavenged, which allows to evaluate free radical scavenging ability of the substance and accordingly determine antioxidant ability thereof.
  • the DPPH radical scavenging ability of the dihydrofuran chalcone was measured through the DPPH radical scavenging assay, so as to evaluate the antioxidant ability of the compound.
  • the assay comprised the following steps:
  • 1,1-Diphenyl-2-picrylhydrazyl (DPPH) was dissolved in absolute ethanol to obtain a solution with a concentration of 0.2 mM.
  • the dihydrofuran chalcone was dissolved in absolute ethanol.
  • 80 ⁇ L of the ethanol solution of dihydrofuran chalcone and 160 ⁇ L of the 0.2 mM DPPH ethanol solution were mixed and the mixture was placed in dark at room temperature for 30 minutes. Then, light absorbance at 517 nm was measured using a microplate reader (SpectraMax 190, Molecular Devices, USA), and Vc was employed as a positive control.
  • results showed that, the dihydrofuran chalcone had an IC 50 value of 32.7 ⁇ M against DPPH radicals, while Vc had an IC 50 value of 100 ⁇ M against DPPH radicals, indicating that the dihydrofuran chalcone of the present invention had an excellent antioxidant ability significantly better than that of the positive control Vc, and thus could be used to prepare antioxidant skin care products, medicines or health products.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A method for preparing a dihydrofuran chalcone includes the following steps: subjecting a Morus alba leaf to extraction with an aqueous solution of methanol or ethanol having a volume fraction of 40%-100%, concentrating an extract to remove methanol or ethanol and dissolving in water, subjecting to extraction with petroleum ether and ethyl acetate successively, and concentrating an ethyl acetate extract to obtain a paste; chromatographing the paste over a silica gel column using chloroform-methanol, collecting an eluate where the volume ratio of chloroform-methanol is 95/5; chromatographing the eluate over a reversed-phase column using acetonitrile-water, collecting an eluate where the volume ratio of acetonitrile-water is 30/70, and thereby the dihydrofuran chalcone is obtained.

Description

    TECHNICAL FIELD
  • The present invention relates to the field of natural product chemistry, particularly relates to a dihydrofuran chalcone compound and a preparation method thereof.
  • BACKGROUND
  • Morus alba is an evergreen macrophanerophyte in the family Moraceae, widely planted in tropical and subtropical regions. Morus alba fruits are sweet and delicious, with high nutritional value and health-care functions, have the effects of treating canities and anti-inflammatory, and thus are well received by consumers. Morus alba leaves, identified as a new vegetable food material, have a fresh taste and have gradually been accepted by consumers. Studies have found that Morus alba leaves are rich in flavonoids and have biological activities such as anti-oxidation, anti-cancer and immunoregulation. However, there are few studies on the active ingredients of Morus alba leaves, and the composition of related active substances remains to be studied.
  • SUMMARY
  • One object of the present invention is to provide a dihydrofuran chalcone and a preparation method thereof.
  • The dihydrofuran chalcone of the present invention is isolated from a Morus alba leaf, and has a structure according to formula (I):
  • Figure US20210332022A1-20211028-C00001
  • A preparation method of the dihydrofuran chalcone, comprises the following steps:
  • subjecting a Morus alba leaf to extraction with an aqueous solution of methanol or ethanol having a volume fraction of 40%-100%, concentrating an extract to remove methanol or ethanol and dissolving in water, subjecting to extraction with petroleum ether and ethyl acetate successively, and concentrating an ethyl acetate extract to obtain a paste; chromatographing the paste over a silica gel column by gradient elution using chloroform-methanol with a volume ratio of 100/0 to 60/40, collecting an eluate where the volume ratio of chloroform-methanol is 95/5; chromatographing the eluate over a reversed-phase column by gradient elution using acetonitrile-water with a volume ratio of 5/95 to 100/0, collecting an eluate where the volume ratio of acetonitrile-water is 30/70, and thereby the dihydrofuran chalcone is obtained.
  • The Morus alba leaf is provided as Morus alba leaf powders, which are obtained by drying a fresh Morus alba leaf and pulverizing into powders.
  • In the step of subjecting the Morus alba leaf to extraction with the aqueous solution of methanol or ethanol having the volume fraction of 40%-100%, the aqueous solution of methanol or ethanol is used according to a proportion of 5 to 20 mL/g Morus alba leaf (i.e., 5 to 20 mL of the aqueous solution of methanol or ethanol is used for one gram of the Morus alba leaf), an extraction temperature is 25° C. to 70° C., and an extraction time is 1 to 72 hours.
  • In the step of concentrating the extract to remove methanol or ethanol and dissolving in water, the extract is concentrated at 40° C. to 80° C. to remove methanol or ethanol, and dissolved by adding water wherein a volume of the water is 1 to 5 times that of the concentrated extract.
  • The step of subjecting to extraction with petroleum ether and ethyl acetate successively, comprises first extracting with petroleum ether for 3 to 12 times and then extracting with ethyl acetate for 3 to 12 times.
  • The present invention also provides an antioxidant skin care product, medicine or health product, which comprises the dihydrofuran chalcone as an active ingredient.
  • It has been confirmed by the present invention that, the dihydrofuran chalcone has a high free radical scavenging capacity. An IC50 value of the compound against DPPH radicals is 32.7 μM, which is significantly lower than the IC50 value of positive control vitamin C (Vc) which is 100 μM, indicating that the dihydrofuran chalcone of the present invention has an excellent antioxidant activity, and thus can be used to prepare antioxidant skin care products, medicines or health products.
  • Compared with the prior art, the present invention has the following advantages:
  • The present invention realizes the preparation of dihydrofuran chalcone by isolating the compound from Morus alba leaves, with a yield of 23 to 157 mg/kg (and a purity of 85% to 95%). The present invention is of great significance for promoting the deep processing and utilization of Morus alba leaves, enhancing the added value of Morus alba leaves products, and promoting the sustainable development of the industry. Furthermore, the invention also provides a novel method for preparing dihydrofuran chalcone.
  • DETAILED DESCRIPTION OF THE EMBODIMENTS
  • The following embodiments are further illustrations of the present invention, but not limitation of the present invention.
  • Embodiment 1
  • 1. Preparation and Isolation of Dihydrofuran Chalcone
  • (1) Materials: Fresh Morus alba leaves were collected and washed with water.
  • (2) Drying and pulverizing: The Morus alba leaves were dried in the sun or in an oven, and then pulverized into powders with a pulverizer.
  • (3) Extraction: An aqueous solution of methanol (40% v/v) was added to the Morus alba leave powders according to a proportion of 5 mL/g Morus alba leaf powders (i.e., 5 mL of the aqueous solution of methanol was used for one gram of the Morus alba leaf powders) to allow extraction at 25° C. for 1 hour. The mixture was then subjected to a filtration process and the filtrate was collected.
  • (4) Organic solvent fractionation: The filtrate was concentrated at 40° C. to remove methanol and give a concentrated solution, followed by the addition of water having the same volume of the concentrated solution. The resulting solution was then successively subjected to extraction with petroleum ether (having the same volume of the resulting solution) for three times and with ethyl acetate (having the same volume of the resulting solution) for three times. The ethyl acetate extracts were concentrated to give a paste which would be subjected to subsequent purification.
  • (5) The paste, obtained by concentrating the ethyl acetate extracts, was chromatographed over a silica gel column (100-200 mesh) by gradient elution using chloroform-methanol with a volume ratio of 100/0 to 60/40, and an eluate was collected where the volume ratio of chloroform-methanol was 95/5. The eluate was then chromatographed over a C18 reversed-phase column by gradient elution using acetonitrile-water with a volume ratio of 5/95 to 100/0, and an eluate was collected where the volume ratio of acetonitrile-water was 30/70. The eluate was then dried by evaporation concentration at 60° C. to give a compound 1, dihydrofuran chalcone.
  • By using this method, a yield of the dihydrofuran chalcone was 23 to 49 mg/kg, with a purity of 85% to 95%.
  • 2. Structure Identification of the Compound 1
  • The compound 1 was easily soluble in methanol. Mass spectrometry results showed that the molecular weight of this compound was 356. 1H NMR (500 MHz, CD3OD) and 13C NMR (125 MHz, CD3OD) data were as listed in Table 1.
  • TABLE 1
    13C and 1H chemical shifts of compound 1
    Position 1H 13C
    1 115.1
    2 160.5
    3 6.35 103.7
    4 161.1
    5 6.37 109.2
    6 7.52 132.4
    1′ 114.7
    2′ 168.1
    3′ 114.6
    4′ 162.1
    5′ 6.37 109.0
    6′ 7.89 133.1
    1″ 3.13 27.9
    2″ 4.74 92.6
    3″ 72.2
    4″ 1.28 25.1
    5″ 1.24 25.3
    α 7.73 117.4
    β 8.09 142.1
    Carbonyl group 194.1
  • In view of the above, the compound 1 was identified to have a structure according to formula (I) and named as dihydrofuran chalcone, easily soluble in methanol.
  • Figure US20210332022A1-20211028-C00002
  • Embodiment 2
  • (1) Materials: Fresh Morus alba leaves were collected and washed with water.
  • (2) Drying and pulverizing: The Morus alba leaves were dried in the sun or in an oven, and then pulverized into powders with a pulverizer.
  • (3) Extraction: An aqueous solution of methanol (100% v/v, i.e., pure methanol) was added to the Morus alba leave powders according to a proportion of 20 mL/g Morus alba leaf powders (i.e., 20 mL of the aqueous solution of methanol was used for one gram of the Morus alba leaf powders) to allow extraction at 60° C. for 72 hours. The mixture was then subjected to a filtration process and the filtrate was collected.
  • (4) Organic solvent fractionation: The filtrate was concentrated at 60° C. to remove methanol and give a concentrated solution, followed by the addition of water having a volume five times that of the concentrated solution. The resulting solution was then successively subjected to extraction with petroleum ether (having the same volume of the resulting solution) for twelve times and with ethyl acetate (having the same volume of the resulting solution) for twelve times. The ethyl acetate extracts were concentrated to give a paste which would be subjected to subsequent purification.
  • The purification step was identical to that in the embodiment 1 to give the compound 1 which was identified to be dihydrofuran chalcone.
  • By using this method, a yield of the dihydrofuran chalcone was 115 to 157 mg/kg, with a purity of 85% to 95%.
  • Embodiment 3
  • (1) Materials: Fresh Morus alba leaves were collected and washed with water.
  • (2) Drying and pulverizing: The Morus alba leaves were dried in the sun or in an oven, and then pulverized into powders with a pulverizer.
  • (3) Extraction: An aqueous solution of ethanol (40% v/v) was added to the Morus alba leave powders according to a proportion of 20 mL/g Morus alba leaf powders (i.e., 20 mL of the aqueous solution of ethanol was used for one gram of the Morus alba leaf powders) to allow extraction at 55° C. for 24 hours. The mixture was then subjected to a filtration process and the filtrate was collected.
  • (4) Organic solvent fractionation: The filtrate was concentrated at 60° C. to remove ethanol and give a concentrated solution, followed by the addition of water having a volume three times that of the concentrated solution. The resulting solution was then successively subjected to extraction with petroleum ether (having the same volume of the resulting solution) for six times and with ethyl acetate (having the same volume of the resulting solution) for six times. The ethyl acetate extracts were concentrated to give a paste which would be subjected to subsequent purification.
  • The purification step was identical to that in the embodiment 1 to give the compound 1 which was identified to be dihydrofuran chalcone.
  • By using this method, a yield of the dihydrofuran chalcone was 55 to 104 mg/kg, with a purity of 85% to 95%.
  • Embodiment 4
  • (1) Materials: Fresh Morus alba leaves were collected and washed with water.
  • (2) Drying and pulverizing: The Morus alba leaves were dried in the sun or in an oven, and then pulverized into powders with a pulverizer.
  • (3) Extraction: An aqueous solution of ethanol (100% v/v, i.e., pure ethanol) was added to the Morus alba leave powders according to a proportion of 5 mL/g Morus alba leaf powders (i.e., 5 mL of the aqueous solution of ethanol was used for one gram of the Morus alba leaf powders) to allow extraction at 70° C. for 48 hours. The mixture was then subjected to a filtration process and the filtrate was collected.
  • (4) Organic solvent fractionation: The filtrate was concentrated at 80° C. to remove ethanol and give a concentrated solution, followed by the addition of water having the same volume of the concentrated solution. The resulting solution was then successively subjected to extraction with petroleum ether (having the same volume of the resulting solution) for six times and with ethyl acetate (having the same volume of the resulting solution) for six times. The ethyl acetate extracts were concentrated to give a paste which would be subjected to subsequent purification.
  • The purification step was identical to that in the embodiment 1 to give the compound 1 which was identified to be dihydrofuran chalcone.
  • By using this method, a yield of the dihydrofuran chalcone was 48 to 96 mg/kg, with a purity of 85% to 95%.
  • Embodiment 5
  • DPPH is a stable free radical. When a free radical scavenger is present, light absorption of DPPH will be reduced when the single electron is scavenged, which allows to evaluate free radical scavenging ability of the substance and accordingly determine antioxidant ability thereof. The DPPH radical scavenging ability of the dihydrofuran chalcone was measured through the DPPH radical scavenging assay, so as to evaluate the antioxidant ability of the compound. The assay comprised the following steps:
  • 1,1-Diphenyl-2-picrylhydrazyl (DPPH) was dissolved in absolute ethanol to obtain a solution with a concentration of 0.2 mM. The dihydrofuran chalcone was dissolved in absolute ethanol. 80 μL of the ethanol solution of dihydrofuran chalcone and 160 μL of the 0.2 mM DPPH ethanol solution were mixed and the mixture was placed in dark at room temperature for 30 minutes. Then, light absorbance at 517 nm was measured using a microplate reader (SpectraMax 190, Molecular Devices, USA), and Vc was employed as a positive control. Results showed that, the dihydrofuran chalcone had an IC50 value of 32.7 μM against DPPH radicals, while Vc had an IC50 value of 100 μM against DPPH radicals, indicating that the dihydrofuran chalcone of the present invention had an excellent antioxidant ability significantly better than that of the positive control Vc, and thus could be used to prepare antioxidant skin care products, medicines or health products.
  • The above descriptions are only preferred embodiments of the present invention. It should be noted that the above preferred embodiments should not be regarded as a limitation to the present invention, and the scope of the present invention shall be defined by the claims. For those of ordinary skill in the art, without departing from the spirit and scope of the present invention, several improvements and modifications can be made, which should also be within the scope of the present invention.

Claims (8)

What is claimed is:
1. (canceled)
2. A method for preparing dihydrofuran chalcone, comprising: isolating the dihydrofuran chalcone from a Morus alba leaf, wherein
the dihydrofuran chalcone has a structure according to formula (I):
Figure US20210332022A1-20211028-C00003
3. The method according to claim 2, wherein, the step of isolating the dihydrofuran chalcone from the Morus alba leaf comprises the following steps:
subjecting the Morus alba leaf to a first extraction with an aqueous solution of methanol or ethanol having a volume fraction of 40%-100% to obtain an extract, concentrating the extract to remove the methanol or ethanol to obtained a concentrated extract and dissolving the concentrated extract in water to obtain a dissolved extract, subjecting the dissolved extract to a second extraction with petroleum ether and ethyl acetate successively to obtain an ethyl acetate extract, and concentrating the ethyl acetate extract to obtain a paste; chromatographing the paste over a silica gel column by a first gradient elution using chloroform-methanol with a volume ratio ranging from 100/0 to 60/40, collecting an first eluate wherein the volume ratio of chloroform-methanol is 95/5; chromatographing the first eluate over a reversed-phase column by a second gradient elution using acetonitrile-water with a volume ratio ranging from 5/95 to 100/0, collecting an second eluate wherein the volume ratio of acetonitrile-water is 30/70 to obtain the dihydrofuran chalcone.
4. The method according to claim 3, wherein, the Morus alba leaf is provided as Morus alba leaf powders, and the Morus alba leaf powders are obtained by drying a fresh Morus alba leaf and pulverizing into powders.
5. The method according to claim 3, wherein, in the step of subjecting the Morus alba leaf to the first extraction with the aqueous solution of methanol or ethanol having the volume fraction of 40%-100%, the aqueous solution of methanol or ethanol is used according to a proportion of 5 to 20 mL/g based on the Morus alba leaf, an extraction temperature of the first extraction ranges from 25° C. to 70° C., and an extraction time of the first extraction ranges from 1 hour to 72 hours.
6. The method according to claim 3, wherein, in the step of concentrating the extract to remove the methanol or ethanol to obtained the concentrated extract and dissolving the concentrated extract in water, the extract is concentrated at 40° C. to 80° C. to remove the methanol or ethanol, and the concentrated extract is dissolved by adding water wherein a volume of the water is 1 to 5 times the concentrated extract.
7. The method according to claim 3, wherein, in the step of subjecting the dissolved extract to the second extraction with the petroleum ether and ethyl acetate successively to obtain the ethyl acetate extract, the second extraction is performed first with the petroleum ether for 3 to 12 times and then with the ethyl acetate for 3 to 12 times.
8-9. (canceled)
US16/626,943 2018-11-01 2018-12-18 Dihydrofuran chalcone compound and preparation method thereof Active 2039-07-07 US11161829B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201811296972.4 2018-11-01
CN201811296972.4A CN109369582B (en) 2018-11-01 2018-11-01 Dihydrofuran chalcone compound and preparation method thereof
PCT/CN2018/121636 WO2020087688A1 (en) 2018-11-01 2018-12-18 Dihydrofuran chalcone compound and preparation method therefor

Publications (2)

Publication Number Publication Date
US20210332022A1 true US20210332022A1 (en) 2021-10-28
US11161829B1 US11161829B1 (en) 2021-11-02

Family

ID=65391414

Family Applications (1)

Application Number Title Priority Date Filing Date
US16/626,943 Active 2039-07-07 US11161829B1 (en) 2018-11-01 2018-12-18 Dihydrofuran chalcone compound and preparation method thereof

Country Status (3)

Country Link
US (1) US11161829B1 (en)
CN (1) CN109369582B (en)
WO (1) WO2020087688A1 (en)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0998939A1 (en) * 1998-09-09 2000-05-10 The School Of Pharmacy, University Of London Chalcone plant extracts for use in therapy
CN102161650B (en) * 2011-03-13 2013-08-07 浙江大学 Polyphenol secondary metabolic products in mulberry leaves and preparation method and application thereof
CN102153534B (en) * 2011-03-13 2013-03-13 浙江大学 Compound with tyrosinase inhibitory activity as well as preparation method and application thereof
CN102161649B (en) * 2011-03-13 2012-07-04 浙江大学 Polyphenol type derivatives extracted from mulberry leaves and preparation method and applications thereof
CN102525853B (en) * 2011-12-23 2013-06-05 广州市娇兰化妆品有限公司 Compound natural plant extract with spot-removing function and preparation method and application thereof
CN102579644B (en) 2012-03-13 2013-09-18 河南中医学院 Compound Chinese hawthorn leaf total flavone dripping pill and preparation method thereof
DE102012105613A1 (en) * 2012-06-27 2014-01-23 Herbert Riepl Refining method useful e.g. for separating biologically active substances from several prenylated polyphenols mixture, comprises e.g. applying solution of mixture on solid phase, eluting biologically active substance and collecting eluates
CN102924421B (en) * 2012-11-04 2014-12-03 浙江大学 Preparation method and application of compound having tyrosinase inhibitory activity
CN104643083B (en) * 2015-03-05 2017-05-10 山西金科海生物科技有限公司 Composition with effects of oxidation resistance and blood fat reduction, and processing technology of composition
CN105001068A (en) 2015-06-23 2015-10-28 江南大学 One-step green synthesis method for hydroxychalcone and flavanone
CN106008172B (en) * 2016-05-18 2019-06-07 江南大学 Preparation method and application of effective part with tyrosinase inhibition effect in mulberry twigs

Also Published As

Publication number Publication date
WO2020087688A1 (en) 2020-05-07
US11161829B1 (en) 2021-11-02
CN109369582A (en) 2019-02-22
CN109369582B (en) 2021-12-10

Similar Documents

Publication Publication Date Title
Goyal et al. Review on ethnomedicinal uses, pharmacological activity and phytochemical constituents of Ziziphus mauritiana (Z. jujuba Lam., non Mill)
US6616943B2 (en) Composition comprising Wenguanguo extracts and methods for preparing same
US11104631B1 (en) Isopentenyl chalcone compound and preparation method thereof
CN113425757A (en) Dandelion extract and preparation method and application thereof
Mukhia et al. Variation in Antioxidant Activity of a Rattan Species, Plectocomia himalayana Griff. by DPPH assay based on two different methods of Methanol Extraction.
US11186533B2 (en) Chalcone compound and preparation method thereof
US11161829B1 (en) Dihydrofuran chalcone compound and preparation method thereof
KR101581240B1 (en) Preparation method of extract of licorice containing Glycyrrhizic acid and Liquiritin
Afroze et al. Proximate analysis, phytochemical screening and antioxidant activity of Psidium guajava leaves growing in coastal area of Bangladesh
WO2022254868A1 (en) Novel isoflavone compound
CN107173805B (en) Health food with function of preventing and treating lung cancer
Verma et al. Antioxidant potential of young pods of Acacia catechu wild collected from Jabalpur region
KR101958439B1 (en) Method for producing Hovenia dulcis beverage product comprising Hovenia dulcis mixed concentrate
Zafar et al. Comparative Evaluation of Phytochemical, Mineral and Vitamin Contents of Gemmomodified Extracts and Leaves of Two Indigenous Medicinal Plants.
JP2015098438A (en) Sugar incorporation promoter
Adamu et al. Estimation of Total Flavonoids and Tannins in the Stem Bark and Leaves of Anogeisus leiocarpus Plant plant
CN109384797B (en) Aromatic tobacco compound and preparation method and application thereof
Tailulu et al. Identification of antimicrobial active components from dry Hainan Morinda citrifolia Linn (Noni) fruit using GC-MS
Adebayo et al. Phytochemical and antioxidant screening of aqueous extract of basella alba for medicinal application
KR20130057145A (en) Composition having physiological activity comprising aster yomena extract
KR100912290B1 (en) Novel 6,8-di?,?-demethylallyl-3,5,7,2',4',6'-hexahydroxy- flavanone or pharmaceutically acceptable salt thereof, preparation method thereof and composition for removing hangover containing the same as an active ingredient
CN110477195B (en) Common sow thistle alkaloid four-stage isolate and separation method and application thereof
Shaikh et al. Qualitative phytochemical screening of leaf extract of Gmelina philippensis Cham and assessment of its antioxidant and antibacterial activity in different solvents
EP0934746B1 (en) Substance in the form of an aqueous extract of vegetal raw material for treating oncological diseases, and method for producing the same
Abbas et al. Potential Role and Mechanism of Mulberry Extract in Immune Modulation: Focus on Chemical Compositions, Mechanistic Insights, and Extraction Techniques

Legal Events

Date Code Title Description
AS Assignment

Owner name: SOUTH CHINA BOTANICAL GARDEN, CHINESE ACADEMY OF SCIENCES, CHINA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:YANG, BAO;JIANG, YUEMING;REEL/FRAME:051433/0992

Effective date: 20191223

FEPP Fee payment procedure

Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

FEPP Fee payment procedure

Free format text: ENTITY STATUS SET TO SMALL (ORIGINAL EVENT CODE: SMAL); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

STCF Information on status: patent grant

Free format text: PATENTED CASE